Disagreement persists in the literature regarding the role of immunodepression in the aetiology and pathogenesis of Crohn's disease. The assessment of immunological function in Crohn's disease has been approached using a variety of methods including the response to skin test antigens (Phear, 1958; Binder et al., 1966; Fletcher and Hinton, 1967; Bolton et al., 1974) lymphocyte transformation with nonspecific mitogens (McHattie et al., 1971; Parent et al., 1971; Aas et al., 1973; Asquith et al., 1973; Guillou et al., 1973; Sachar et al., 1973; Bird and Britton, 1974) lymphocyte transformation in mixed lymphocyte cultures (Richens et al., 1974) , and enumeration of circulating B and T lymphocytes (Ropke, 1972; Bird and Britton, 1974) . In several instances, evidence for immunological impairment has been found based on the results of these tests. However, an equal number of conflicting 'These studies were supported by the John A. Hartford Foundation, Received for publication 3 December 1975. results, using the same methods, has been obtained such that the influence of immunological factors in Crohn's disease remains unclear. Most previous studies have limited themselves to the use of a single method in assessing immunocompetence. We therefore undertook a comprehensive analysis of immunological function in our patients with Crohn's disease, correlating results obtained using several different methods. The results of these studies form the basis of this report.
Methods

PATIENTS
Thirty-eight patients with documented Crohn's disease were studied. Twenty-five patients were receiving azulfidine and/or antidiarrhoeal medication or no treatment at the time they were studied. Fourteen other Crohn's disease patients were receiving immunosuppressive agents consisting either of azathioprine, or prednisone, or both. One patient (B.S.) was studied twice, once while receiving no medication and once while receiving prednisone.
The clinical characteristics of the non-immunosuppressed patients with Crohn's disease are listed in Table 1 .
Disease activity was estimated using the criteria developed for the National Cooperative Crohn's Disease Study (Best et al., in press Measurements of tritiated thymidine uptake by to be whole blood culture technique (Pauly and Sokal, 1972) were used for quantitative assessments of lymphocyte reactivity. Ten millilitres of venous blood were drawn into plastic syringes containing 25 U sodium heparin (Upjohn beef lung heparin preserved with benzyl alcohol). Specimens were kept at room temperature and used within 18 hours. Absolute lymphocyte counts were performed. Cell suspensions were prepared for culture by diluting one volume of whole blood with 19 volumes of synthetic tissue culture medium (RPMI 1640, Grand Island Biological Co.) containing 100 U/ml penicillin and 100 ,ug/ml streptomycin. This dilution of whole blood (1:20) was determined by experiment to give adequate stimulation values and ease in subsequent solubilization procedures. No serum supplements were added. Cultures, usually in five-fold replicates, contained 3 ml cell suspension in disposable 16 x 100 mm glass tubes with nonsealing plastic closures. Reconstituted phytohaemagglutinin (Burroughs Wellcome Co., MR 68), 0-4 ml/culture, or pokeweed mitogen (PWM, Grand Island Biological Co.), 0-32 mg in 0.4 ml/culture, were added to appropriate replicate cultures to test for T cell and combined T and B cell reactivity respectively. After 96 hours incubation at 37°C in a 5 % C02 humidified atmosphere, 3H-thymidine (sp. act. 1 9 Ci/mMol, New England Nuclear), 1I0 ,uCi per tubewas added to each culture and incubated for another 24 hours. Cells were harvested by resuspending the cell button, transferring the cell suspension to centrifuge tubes, and rinsing the culture tubes with cold 3% acetic acid. The rinse was added to the centrifuge tubes and the tubes were filled with cold 3 % acetic acid. The tubes were centrifuged at 150 g for 10 minutes. The cell button was washed once in cold acid, recentrifuged, and the supernatant solution decanted. One drop of 30% hydrogen peroxide was added to each of the cell buttons after which the pellets were warmed to 85°C for 20 minutes in a drying oven. Preliminary experiments, using a three day rather than a seven day incubation period for lymphocytes stimulated with PHA, produced unexpected results in eight patients with untreated Crohn's disease compared with 11 normal controls (Table 5 ). Both absolute counts and stimulation ratios were significantly greater in stimulated cultures from the normal individuals than in the patients with Crohn's disease. This suggests that lymphocytes from Crohn's disease patients might be less responsive to mitogens initially, although they respond in a quantitatively normal fashion when conditions are optimal.
MISCELLANEOUS
Isohaemagglutinins were detected in the serums of all patients with blood groups A, B, and 0. Serum immunoglobulins were measured in 27 patients with Crohn's disease, including 18 non-immunosuppressed patients and nine patients receiving steroids. The data obtained are given in steroids. The levels of IgG and IgM fell within the normal range for our laboratory. Elevation of serum IgA in Crohn's disease has been reported previously (Bolton et al., 1974; Jones et al., in press ). Absolute lymphocyte counts were calculated for the patients with Crohn's disease and controls. Patients with Crohn's disease tended to have higher lymphocyte counts than controls, excluding the patients with malignant LPD. Non immunosuppressed patients with inactive Crohn's disease showed no elevation of lymphocyte counts. These data are included in Table 6 .
Discussion
The results reported here suggest that the aspects of the immune response which we measured in patients with Crohn's disease are qualitatively normal. A variety of immunological tests were employed, none of which differentiated between non-immunosuppressed patients with Crohn's disease and controls.
Attempts to sensitize patients with DNCB were successful in 94% (16 of 17) of individuals with Crohn's disease who were not receiving immunosuppressive therapy. In contrast, none of the immunosuppressed patients developed DNCB sensitization.
Verrier-Jones found that 58% of patients with Crohn's disease failed to develop sensitivity to DNCB and that this unresponsiveness was not correlated with disease activity (Jones et al., 1969) . However, Bolton et al. (1974) found that 80% of Crohn's disease patients developed sensitivity to DNCB similar to results in controls and in closer agreement with our studies.
The results of skin tests using the battery of common skin test antigens illustrate several points. Steroid-treated patients tended to be less responsive to these antigens than other patient groups. Nevertheless, many such patients continued to develop strong reactions despite steroid treatment. Patients with active Crohn's disease who were not receiving immunosuppressive agents also reacted less intensely and less frequently to these antigens, but only two of eight such patients failed to react to at least one of the common skin test antigens. Both unreactive patients were relatively young (26 and 32 years respectively) and each developed an intense flare reaction at the high dose primary sensitization site with DNCB. Their failure to react to the recall antigens might reflect a lack of exposure to these antigens rather than immunological impairment. Binder also reported that patients with Crohn's disease reacted to skin test antigens as frequently as controls (Binder et al., 1966) .
The results of the lymphocyte transformation assays corroborate the skin test results. Only patients with lymphoproliferative disorders differed significantly from the other groups tested. Normal individuals tended to incorporate tritiated thymidine more readily in both mitogen stimulated and unstimulated lymphocyte cultures. Stimulation ratios for normal individuals, hospitalized controls, and Crohn's disease patients were similar. This was true whether their disease were judged to be active or not. Patients receiving steroids were similar to the other patient groups with regard to lymphocyte responsiveness in vitro. However, none of the steroidtreated patients developed a positive skin test reaction after sensitization with DNCB.
Experiments using the whole blood PHAinduced lymphocyte transformation technique revealed that short, suboptimal incubation periods produced stimulation ratios which discriminated between Crohn's disease patients and normal individuals. The optimal seven day incubation abolished this difference. This observation might explain some discrepant results which have appeared in the literature. Recently, investigators employing PNA-induced lymphocyte stimulation have emphasized the value of dose response curves studied over multiple time intervals in detecting immunological impairment. It should be noted that Ropke, in a study of patients with Crohn's disease, found no difference in lymphocyte kinetics after PHA stimulation (Ropke, 1972) .
The explanation for this observation is not known. Strickland et al., in a recent study of T and B lymphocytes in peripheral blood of patients with Crohn's disease, found that T lymphocytes were modestly depressed (Strickland et al., 1974) . However, similar investigations by Bird and Britton failed to confirm this observation (Bird and Britton, 1974) . Alternatively, hyporesponsiveness to mitogen stimulation in other conditions has occasionally been associated with serum inhibitors (Socia-Foca et al., 1973) , medications including both salicylates (Crout et al., 1975) and steroids (Walker and Greaves, 1969) , and malnutrition (Law et al., 1973) .
The explanation for the conflicting results reported in the literature regarding cell-mediated immunity in Crohn's disease is unclear and undoubtedly complex. Patients with Crohn's disease vary in their disease activity, duration of disease, age, nutritional status, and therapy. Each of these variables might influence the results of immunological tests. Moreover, our ability to translate the results of the crude immunological tests at our disposal into meaningful clinical correlations is extremely limited except in the most obvious of clinical situations such as the immune deficiency diseases and malignancies of the lymphoreticular system. Until more discriminating methods become available, we contend that immune depression in Crohn's disease has not been proven and that the role of depressed immunity in the pathogenvsis of Crohn's disease is uncertain. 
